肝细胞自分泌运动因子表达促进肝纤维化与肝癌发生
研究显示慢性肝病患者肝细胞自分泌运动因子(ATX)表达升高且与总生存期缩短相关;小鼠中肝毒性刺激诱导肝细胞ATX表达,升高溶血磷脂酸(LPA)水平、激活肝星状细胞并放大促纤维化信号;肝细胞ATX缺失或过表达及药物抑制实验表明ATX/LPA促进肝纤维化并参与肝硬化向肝细胞癌的致病联系。
要点
- 慢性肝病患者肝细胞ATX表达升高,且与总生存期缩短相关。
- 小鼠中肝毒性刺激诱导肝细胞ATX表达,升高LPA并激活肝星状细胞。
- 肝细胞ATX缺失可减轻肝细胞癌发生,提示ATX/LPA参与肝硬化至肝癌联系。
核心结论
- ATX是肝纤维化和肝癌发病机制中的新参与者,也是有前景的治疗靶点。
研究设计与样本
- 研究检测了不同病因慢性肝病患者的ATX表达,并在小鼠中采用肝毒性刺激、肝细胞特异性条件性基因缺失和/或转基因过表达及药物性ATX抑制进行研究。
- 原文未报告样本量。
主要发现
- 不同病因慢性肝病患者中检测到ATX表达升高,且与较短总生存期相关。
- 小鼠中与不同形式慢性肝病相关的不同肝毒性刺激可刺激肝细胞ATX表达,导致LPA水平升高、肝星状细胞活化及促纤维化信号放大。
- 肝细胞特异性条件性基因缺失和/或转基因过表达确立了ATX/LPA的肝脏促纤维化作用。
- 药物性ATX抑制研究提示ATX可能是慢性肝病的治疗靶点。
- 肝细胞ATX缺失及随之的脂质稳态失调可减弱肝细胞癌发生,提示ATX/LPA参与肝硬化与肝细胞癌的致病联系。
临床怎么用
- 作者认为ATX是有前景的治疗靶点;药物性ATX抑制研究提示ATX可能是慢性肝病的治疗靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Autotaxin (ATX) is a secreted lysophospholipase D that catalyzes the production of lysophosphatidic acid (LPA), a pleiotropic growth-factor-like lysophospholipid. Increased ATX expression has been detected in various chronic inflammatory disorders and different types of cancer; however, little is known about its role and mode of action in liver fibrosis and cancer. Here, increased ATX expression was detected in chronic liver disease (CLD) patients of different etiologies, associated with shorter overall survival. In mice, different hepatotoxic stimuli linked with the development of different forms of CLDs were shown to stimulate hepatocyte ATX expression, leading to increased LPA levels, activation of hepatic stellate cells (HSCs), and amplification of profibrotic signals. Hepatocyte-specific, conditional genetic deletion and/or transgenic overexpression of ATX established a liver profibrotic role for ATX/LPA, whereas pharmacological ATX inhibition studies suggested ATX as a possible therapeutic target in CLDs. In addition, hepatocyte ATX ablation and the consequent deregulation of lipid homeostasis was also shown to attenuate hepatocellular carcinoma (HCC) development, thus implicating ATX/LPA in the causative link of cirrhosis and HCC. CONCLUSION: ATX is a novel player in the pathogenesis of liver fibrosis and cancer and a promising therapeutic target. (Hepatology 2017;65:1369-1383).
引用
- Kaffe E, Katsifa A, Xylourgidis N, et al. Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology. 2017. PMID: 27981605. doi:10.1002/hep.28973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。